Imatinib and nilotinib are equally successful in achieving therapy-free remission
伊马替尼和尼洛替尼在实现无治疗缓解方面同样有效。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01462-6
Cheng, Fang; Wang, Yu; Yang, Yunfan; Du, Xin; Zhu, Yu; Weng, Jianyu; Xu, Na; Huang, Jian; Liu, Zhenfang; Ren, Hongbo; Zhao, Huifang; Zhu, Huanling; Jiang, Qian; Zhang, Yanli; Li, Weiming